TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biosort AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,600
|
6,620
|
4,814 |
Financial expenses |
3
|
4
|
1 |
Earnings before taxes |
455
|
541
|
778 |
Total assets |
4,383
|
4,742
|
3,406 |
Current assets |
3,906
|
4,484
|
3,128 |
Current liabilities |
599
|
1,119
|
881 |
Equity capital |
3,154
|
2,957
|
1,819 |
- share capital |
313
|
335
|
343 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.0%
|
62.4%
|
53.4% |
Turnover per employee | |||
Profit as a percentage of turnover |
8.1%
|
8.2%
|
16.2% |
Return on assets (ROA) |
10.4%
|
11.5%
|
22.9% |
Current ratio |
652.1%
|
400.7%
|
355.1% |
Return on equity (ROE) |
14.4%
|
18.3%
|
42.8% |
Change turnover |
-600
|
2,060
|
1,349 |
Change turnover % |
-10%
|
45%
|
39% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.